 Quoin Pharmaceuticals NASDAQ: QNRX shares are trading higher Monday after the company announced it received U.S. Food and Drug Administration clearance to initiate clinical testing for its Investigational New Drug application for QRX003. QRX003 is Quoins investigational product for. 